fenoldopam and Hypertension, Renal studies

fenoldopam and Hypertension, Renal

fenoldopam has been researched along with Hypertension, Renal in 3 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.

Research Excerpts

Excerpt	Relevance	Reference
"Fenoldopam treatment significantly increased urine output as well as urinary sodium indicating reduced sodium retention."	5.32	Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats. ( Goyal, RK; Umrani, DN, 2003)
"Fenoldopam treatment significantly increased urine output as well as urinary sodium indicating reduced sodium retention."	1.32	Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats. ( Goyal, RK; Umrani, DN, 2003)
"Fenoldopam treatment significantly reduced fasting but not fed blood glucose levels and lowered the blood pressure in diabetic animals."	1.31	Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats. ( Goyal, RK; Umrani, DN, 2002)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

3 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Umrani, DN	2
Goyal, RK	2
Venkatakrishnan, U	1
Chen, C	1
Lokhandwala, MF	1

Studies

Umrani, DN

Goyal, RK

Venkatakrishnan, U

Chen, C

Lokhandwala, MF

Other Studies

3 other studies available for fenoldopam and Hypertension, Renal

Article	Year
Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2003, Volume: 25, Issue:4 Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2;	2003
The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation. Clinical and experimental hypertension (New York, N.Y. : 1993), 2000, Volume: 22, Issue:3 Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dopamine; Dopamine Agonists; Enzyme Inhibitors;	2000
Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2002, Volume: 24, Issue:3 Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatinine; Di	2002

Article

Year

Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2003, Volume: 25, Issue:4

Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2;

2003

The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2000, Volume: 22, Issue:3

Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dopamine; Dopamine Agonists; Enzyme Inhibitors;

2000

Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2002, Volume: 24, Issue:3

Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatinine; Di

2002